Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 29, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

A gene expression ratio-based diagnostic test for bladder cancer.

Lingsheng Dong1, Andrew J Bard, William G Richards

  • 1The Thoracic Surgery Oncology laboratory and the Division of Thoracic Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Advances and Applications in Bioinformatics and Chemistry : AABC
|September 16, 2011
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating Mosaic Loss of the Y Chromosome in Male Bladder Cancer Participants Using "All of Us" Data.

Studies in health technology and informatics·2026
Same author

Beyond sex determination: the Y chromosome in male cancers.

Nature reviews. Cancer·2026
Same author

ZFP148 is a transcriptional repressor of cytolytic effector CD8<sup>+</sup> T cell differentiation.

Nature immunology·2026
Same author

Bladder cancer journal as official IBCN partner; strengthening global collaboration in bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2025
Same author

Loss of the Y chromosome drives cancer metabolic reprogramming.

bioRxiv : the preprint server for biology·2025
Same author

Genes driving three-dimensional growth of immortalized cells and cancer.

Cell death & disease·2025

A new gene expression ratio test accurately diagnosed bladder cancer in 100% of samples. This method shows promise for improving early detection of bladder cancer, potentially aiding cytopathology screening.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biotechnology

Background:

  • Bladder cancer diagnosis relies on methods like cystoscopy and cytology, which have limitations.
  • Early detection is crucial for effective bladder cancer treatment.
  • Novel diagnostic approaches are needed to improve accuracy and accessibility.

Purpose of the Study:

  • To evaluate a novel diagnostic method for bladder cancer based on gene expression ratios.
  • To determine the clinical relevance and accuracy of this gene expression-based technique for bladder cancer detection.

Main Methods:

  • Developed a diagnostic model using gene expression profiling data from normal and tumor bladder tissues.
  • Identified statistically significant genes with reciprocal expression levels.
Keywords:
and diagnosisbladder cancergene expression profiling

More Related Videos

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

Related Experiment Videos

Last Updated: May 29, 2026

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System
06:23

A Murine Orthotopic Bladder Tumor Model and Tumor Detection System

Published on: January 12, 2017

Cell-Free DNA Integrity Analysis in Urine Samples
07:58

Cell-Free DNA Integrity Analysis in Urine Samples

Published on: January 5, 2017

  • Calculated gene pair expression ratios to assign diagnoses, validated with microarray data and RT-PCR.
  • Main Results:

    • A five-ratio test using six genes achieved 100% accuracy in distinguishing benign from malignant bladder tissues.
    • The diagnostic model was validated across multiple datasets and patient cohorts.
    • Statistical significance (P < 10(-6)) confirmed the robustness of the findings.

    Conclusions:

    • Gene expression ratios offer a promising approach for bladder cancer diagnosis.
    • This technique serves as a proof-of-principle for a new diagnostic tool.
    • May complement existing cytopathology methods for urine-based bladder cancer screening.